| __timestamp | Ligand Pharmaceuticals Incorporated | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 55402000 | 21595165 |
| Thursday, January 1, 2015 | 66107000 | 6590427 |
| Friday, January 1, 2016 | 103402000 | 11768542 |
| Sunday, January 1, 2017 | 135736000 | 92587038 |
| Monday, January 1, 2018 | 245116000 | 129203843 |
| Tuesday, January 1, 2019 | 108935000 | 165412447 |
| Wednesday, January 1, 2020 | 156000000 | 203056430 |
| Friday, January 1, 2021 | 214957000 | 169670071 |
| Saturday, January 1, 2022 | 143418000 | 188060000 |
| Sunday, January 1, 2023 | 96265000 | 220104000 |
Unleashing the power of data
In the ever-evolving landscape of biopharmaceuticals, understanding financial trends is crucial. This analysis delves into the gross profit trajectories of two industry players: Pharming Group N.V. and Ligand Pharmaceuticals Incorporated from 2014 to 2023.
Ligand Pharmaceuticals, known for its innovative drug discovery technologies, saw a remarkable 340% increase in gross profit from 2014 to 2018, peaking in 2018. However, a decline followed, with a 60% drop by 2023. In contrast, Pharming Group N.V., a leader in rare disease treatments, experienced a steady rise, with a 920% increase over the same period, culminating in 2023.
This divergence highlights the dynamic nature of the sector, where strategic focus and market conditions can significantly impact financial outcomes. Investors and stakeholders should consider these trends when evaluating potential opportunities in the biopharmaceutical industry.
Gross Profit Analysis: Comparing Johnson & Johnson and Pharming Group N.V.
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Ligand Pharmaceuticals Incorporated Trends
Regeneron Pharmaceuticals, Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Pharming Group N.V.
Alnylam Pharmaceuticals, Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Genmab A/S and Ligand Pharmaceuticals Incorporated Trends
Gross Profit Trends Compared: Viatris Inc. vs Ligand Pharmaceuticals Incorporated
Key Insights on Gross Profit: Bio-Techne Corporation vs Ligand Pharmaceuticals Incorporated
Gross Profit Analysis: Comparing Pharming Group N.V. and Lantheus Holdings, Inc.
Gross Profit Analysis: Comparing Pharming Group N.V. and Corcept Therapeutics Incorporated
Breaking Down Revenue Trends: Pharming Group N.V. vs Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and Ligand Pharmaceuticals Incorporated